COVID-19 Updates
Conference Coverage
COVID-19: A ‘marathon, not a sprint’ for psychiatry
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
Feature
New study of diabetes drug for COVID-19 raises eyebrows
From the Journals
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Latest News
Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab
Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.
News
POPCoRN network mobilizes pediatric capacity during pandemic
The Pediatric Overflow Planning Contingency Response Network has worked like medical crowd sourcing.
Latest News
IDSA guidelines cover N95 use and reuse
Conference Coverage
COVID-19: An opportunity, challenge for addiction treatment, NIDA boss says
Right now, said Dr. Nora Volkow, “we are in the dark as to how COVID infections have affected the number of overdose deaths.”
News
Trials and tribulations: Neurology research during COVID-19
Many researchers have redesigned their studies, at least in part to optimize the safety of their participants and research staff.
Latest News
Remdesivir now ‘standard of care’ for COVID-19, Fauci says
The interim results show that time to recovery was 31% faster for patients who received remdesivir than for those who received placebo.
From the Journals
Standing orders for vaccines may improve pediatric vaccination rates